These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32330444)

  • 1. Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3.
    Posfai D; Maher SP; Roesch C; Vantaux A; Sylvester K; Péneau J; Popovici J; Kyle DE; Witkowski B; Derbyshire ER
    Cell Chem Biol; 2020 Jun; 27(6):719-727.e5. PubMed ID: 32330444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Tubovesicular Network in
    Sylvester K; Maher SP; Posfai D; Tran MK; Crawford MC; Vantaux A; Witkowski B; Kyle DE; Derbyshire ER
    Front Cell Infect Microbiol; 2021; 11():687019. PubMed ID: 34195101
    [No Abstract]   [Full Text] [Related]  

  • 3. A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages.
    Schafer C; Dambrauskas N; Steel RW; Carbonetti S; Chuenchob V; Flannery EL; Vigdorovich V; Oliver BG; Roobsoong W; Maher SP; Kyle D; Sattabongkot J; Kappe SHI; Mikolajczak SA; Sather DN
    Malar J; 2018 Oct; 17(1):370. PubMed ID: 30333026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infection.
    Posfai D; Sylvester K; Reddy A; Ganley JG; Wirth J; Cullen QE; Dave T; Kato N; Dave SS; Derbyshire ER
    PLoS Pathog; 2018 May; 14(5):e1007057. PubMed ID: 29775485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax pre-erythrocytic stages and the latent hypnozoite.
    Zanghi G; Vaughan AM
    Parasitol Int; 2021 Dec; 85():102447. PubMed ID: 34474178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites.
    Gural N; Mancio-Silva L; Miller AB; Galstian A; Butty VL; Levine SS; Patrapuvich R; Desai SP; Mikolajczak SA; Kappe SHI; Fleming HE; March S; Sattabongkot J; Bhatia SN
    Cell Host Microbe; 2018 Mar; 23(3):395-406.e4. PubMed ID: 29478773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice.
    Mikolajczak SA; Vaughan AM; Kangwanrangsan N; Roobsoong W; Fishbaugher M; Yimamnuaychok N; Rezakhani N; Lakshmanan V; Singh N; Kaushansky A; Camargo N; Baldwin M; Lindner SE; Adams JH; Sattabongkot J; Kappe SH
    Cell Host Microbe; 2015 Apr; 17(4):526-35. PubMed ID: 25800544
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
    Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
    [No Abstract]   [Full Text] [Related]  

  • 9. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
    Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
    Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Flannery EL; Kangwanrangsan N; Chuenchob V; Roobsoong W; Fishbaugher M; Zhou K; Billman ZP; Martinson T; Olsen TM; Schäfer C; Campo B; Murphy SC; Mikolajczak SA; Kappe SHI; Sattabongkot J
    Mol Ther Methods Clin Dev; 2022 Sep; 26():427-440. PubMed ID: 36092359
    [No Abstract]   [Full Text] [Related]  

  • 11. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.
    Roth A; Maher SP; Conway AJ; Ubalee R; Chaumeau V; Andolina C; Kaba SA; Vantaux A; Bakowski MA; Thomson-Luque R; Adapa SR; Singh N; Barnes SJ; Cooper CA; Rouillier M; McNamara CW; Mikolajczak SA; Sather N; Witkowski B; Campo B; Kappe SHI; Lanar DE; Nosten F; Davidson S; Jiang RHY; Kyle DE; Adams JH
    Nat Commun; 2018 May; 9(1):1837. PubMed ID: 29743474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
    Gualdrón-López M; Díaz-Varela M; Zanghi G; Aparici-Herraiz I; Steel RWJ; Schäfer C; Cuscó P; Chuenchob V; Kangwangransan N; Billman ZP; Olsen TM; González JR; Roobsoong W; Sattabongkot J; Murphy SC; Mikolajczak SA; Borràs E; Sabidó E; Fernandez-Becerra C; Flannery EL; Kappe SHI; Del Portillo HA
    Mol Cell Proteomics; 2022 Oct; 21(10):100406. PubMed ID: 36030044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethiopian Plasmodium vivax hypnozoites formation dynamics and their susceptibility to reference antimalarial drugs.
    Dembele L; Diakite O; Sogore F; Kedir S; Tandina F; Maiga M; Abate A; Golassa L; Djimde AA
    BMC Infect Dis; 2023 Jun; 23(1):405. PubMed ID: 37312065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
    White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
    Elife; 2014 Nov; 3():. PubMed ID: 25406065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The
    Gupta DK; Dembele L; Voorberg-van der Wel A; Roma G; Yip A; Chuenchob V; Kangwanrangsan N; Ishino T; Vaughan AM; Kappe SH; Flannery EL; Sattabongkot J; Mikolajczak S; Bifani P; Kocken CH; Diagana TT
    Elife; 2019 May; 8():. PubMed ID: 31094679
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-cell RNA profiling of 
    Ruberto AA; Maher SP; Vantaux A; Joyner CJ; Bourke C; Balan B; Jex A; Mueller I; Witkowski B; Kyle DE
    Front Cell Infect Microbiol; 2022; 12():986314. PubMed ID: 36093191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-stage fate determination in
    Vantaux A; Péneau J; Cooper CA; Kyle DE; Witkowski B; Maher SP
    Front Microbiol; 2022; 13():976606. PubMed ID: 36212849
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.
    Chattopadhyay R; Velmurugan S; Chakiath C; Andrews Donkor L; Milhous W; Barnwell JW; Collins WE; Hoffman SL
    PLoS One; 2010 Dec; 5(12):e14275. PubMed ID: 21151554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium vivax liver stage assay platforms using Indian clinical isolates.
    Subramani PA; Vartak-Sharma N; Sreekumar S; Mathur P; Nayer B; Dakhore S; Basavanna SK; Kalappa DM; Krishnamurthy RV; Mukhi B; Mishra P; Yoshida N; Ghosh SK; Shandil R; Narayanan S; Campo B; Hasegawa K; Anvikar AR; Valecha N; Sundaramurthy V
    Malar J; 2020 Jun; 19(1):214. PubMed ID: 32571333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Activation-Clearance Model for Plasmodium vivax Malaria.
    Mehra S; McCaw JM; Flegg MB; Taylor PG; Flegg JA
    Bull Math Biol; 2020 Feb; 82(2):32. PubMed ID: 32052192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.